BeStock  

Eton Pharmaceutical ETON

US equityMarket cap rank #2769Drug Manufacturers - Specialty & Generic
$60.85 −$0.51 (-0.83%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $60.85 0.00%
Open$61.00
Prev close$61.36
Day range$59.18 – $61.65
Volume562.7K
Market cap$1.76B
P/E (TTM)39.5
Dividend yield–

ETON Stock News

Headlines matching Eton Pharmaceutical or the ETON ticker, most recent first.

  • Eton Pharmaceuticals Announces U.S. Commercial Availability of IMPAVIDO (Miltefosine) CapsulesGlobeNewswire · 28 Sep 2026 · Direct mention
  • Eton Pharmaceutical(ETON.US) Officer Sells US$6.09 Million in Common StockMarket news · 21 Aug 2026 · Direct mention
  • Upgrade: Analysts Just Made A Notable Increase To Their Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Forecasts PositiveSimply Wall St · 19 Aug 2026 · Direct mention
  • B. Riley Adjusts Price Target on Eton Pharmaceuticals to $70 From $40, Maintains Buy RatingMT Newswires · 14 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Raises Target Price to $70 PositiveMarket news · 14 Aug 2026 · Direct mention
  • Craig-Hallum Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Raises Target Price to $76 PositiveMarket news · 14 Aug 2026 · Direct mention
  • Craig-Hallum Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Maintains Target Price $62Market news · 13 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Raises Target Price to $65 PositiveMarket news · 11 Aug 2026 · Direct mention
  • 4: Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-10% Owner Opaleye Management Inc.SEC · 8 Jul 2026 · Direct mention
  • CCORF Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Maintains Target Price $60Market news · 30 Jul 2026 · Direct mention
  • Craig-Hallum Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Announces Target Price $62Market news · 28 Jul 2026 · Direct mention
  • 4/A: Eton Pharmaceutical | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-10% Owner Opaleye Management Inc.SEC · 18 Jul 2026 · Direct mention
  • CCORF Initiates Eton Pharmaceutical(ETON.US) With Buy Rating, Announces Target Price $60Market news · 17 Jul 2026 · Direct mention
  • 4: Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-10% Owner Opaleye Management Inc.SEC · 17 Jul 2026 · Direct mention
  • B. Riley Securities Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Maintains Target Price $40Market news · 27 Jun 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on ETON.

Sign in to join the discussion.

Scroll to Top